We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Glyoxalase I Ala111Glu gene polymorphism: No association with breast cancer risk but correlated with absence of progesterone receptor.
- Authors
Naidu, Rakesh; Yip Cheng Har; Taib, Nur Aishah Mohd
- Abstract
The aim of the present study was to evaluate the association between the Glyoxalase I (GLOI) Ala111Glu polymorphism and breast cancer risk among the major Malaysian ethnic groups, the Malays, Chinese and Indians, as well as clinico-pathological characteristics of these patients. Genotyping of GLOI gene was performed on blood samples obtained from 387 patients and 252 normal healthy women who had no history of any malignancy using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The genotype and allele frequencies of GLOI polymorphism were not significantly different between the patients and normal individuals among the Malays ( P= 0.721, 0.402), Chinese ( P= 0.208, 0.079) and Indians ( P= 0.612, 0.349), respectively. The Malay, Chinese and Indian women who were Glu/Glu homozygotes ( P= 0.419, 0.093, 0.367), Ala/Glu heterozygotes ( P= 0.648, 0.182, 0.402) and carriers of Glu allele ( P= 0.402, 0.079, 0.349), respectively, were not associated with breast cancer risk. The Glu allele genotype was significantly associated with absence of progesterone receptor ( P= 0.036). Thus, the polymorphic variant of the GLOI gene might not be a useful genetic marker to identify Malaysian Malay, Chinese or Indian women who could be at greater risk of developing breast cancer.
- Subjects
GLYOXALASE; BREAST cancer; CANCER in women; GENETIC polymorphisms; GENETIC carriers; ETHNIC groups
- Publication
Pathology International, 2010, Vol 60, Issue 9, p614
- ISSN
1320-5463
- Publication type
Article
- DOI
10.1111/j.1440-1827.2010.02568.x